Clinical trials, adaptability and the COVID-19 pandemic.

Despite the impact of the COVD-19 pandemic and public health crisis on health care delivery, the GOG-Foundation has continued to prioritize the delivery of novel and state-of-the-science treatment options to patients via clinical trials.

Informations de copyright

© 2020 The Author.

Déclaration de conflit d'intérêts

Dr. Eskander reports personal fees and/or institutional support/grants for clinical research outside of the submitted work; AstraZeneca, Clovis, Merck, GSK/Tesaro, Eisai, Genentech/Roche, Myriad and GOG Foundation. Institutional PI for industry sponsored trials from CLOVIS, Roche/Genentech, and AstraZeneca. Dr. Pothuri reports grants, personal fees and non-financial support outside of the submitted work; institutional PI for industry sponsored trials from Tesaro/GSK, AstraZeneca, Merck, Genentech/Roche, Celsion, and Clovis Oncology. Compensated advisory boards include Tesaro/GSK, Astra Zeneca, Merck, Eisai, and Mersana. Dr. Randall reports grants, personal fees and non-financial support outside of the submitted work from BluPrint Oncology, AstraZeneca, Clovis, Novocure, GOG Foundation, Merck, Mersana, Agenus, Tesaro/GSK, Genentch/Roche, On Target Laboratories, Pfizer, Aivita Biomedical, Akeso Biopharma, and GEICO. Dr. O’Malley reports personal fees and/or institutional support for clinical research from AstraZeneca, Clovis, Tesaro/GSK, Immunogen, Ambry, Janssen/J&J, Abbvie, Regeneron, Amgen, Novocure, Genentech/Roche, VentiRx, Array Biopharma, EMD Serono, Ergomed, Ajinomoto Inc., Ludwig Cancer Research, Stemcentrx, Inc, Cerulean Pharma, GOG Foundation, Bristol-Myers Squibb Co, Serono Inc, Tracon Pharmaceuticals, Yale University, New Mexico Cancer Care Alliance, INC Research, Inc, inVentiv Health Clinical, Iovance Biotherapeutics, Inc, PRA Intl, Myriad Genetics, Eisai, Agenus, Tarveda and Merck. Dr. Slomovitz reports personal fees and non-financial support outside of the submitted work from: Clovis, Abbvie, AstraZeneca, GSK, Genentech/Roche, and the GOG foundation Dr. Moore reports grants, personal fees and non-financial support outside of the submitted work; advisory board participation for: Astra Zeneca, Abbvie, Aravie, Eisai, GSK/Tesaro, Genentech/Roche, Immunogen, Mersana, Merck, Myriad, VBL Therapeutics, Vavotar and Tarveda. Research Funding from PTC Therapeutics, Lilly, Merck and GSK/Tesaro Dr. Coleman reports consulting and/or research support funding from AstraZeneca, Merck, Tesaro/GSK, Medivation, Clovis, Gamamab, Genmab, Roche/Genentech, Janssen, Agenus, Regeneron and OncoQuest. Dr. Herzog reports consulting and serving on scientific advisory boards for AstraZeneca, Clovis, Caris, Genentech/Roche, GSK, J&J and Merck. Dr. Monk reports honoraria and consulting fees from Abbvie, Agenus, Akeso Bio, Aravive, AstraZeneca, Clovis, Eisai, EMD Serono/Merck, Genmab/Seattle Genetics, GOG Foundation, Gradalis, ImmunoGen, Iovance, Merck, Mersana, Myriad, Pfizer, Puma, Roche/Genentech, Starton Therpaeutics, Tesaro/GSK, Vavotar Life Sciences, VBL. Dr. Copeland reports no personal disclosures